Combining cutting-edge science with high quality to accelerate your drug development

Biogazelle is a CRO specializing in high-value applications to support pharmaceutical research, clinical trials and diagnostic test development.

To accelerate the development of small molecules, RNA targeted drugs, and adoptive cell therapies, we apply a suite of genomic and transcriptomic technologies, to find and validate RNA biomarkers, and to assess efficacy, safety, and toxicity.

We hold a unique forefront position in the application of quantitative PCR, digital PCR and dedicated RNA sequencing workflows on precious clinical samples such as liquid biopsies and FFPE tissues.